Second Wave of COVID-19

BSE S&P Sensex was down by 1,148 points or 2.35 percent lower at 47,684 while the Nifty 50 dipped by 329 points or 2.25 percent to 14,289 Equity benchmark i

WHO has said that there is still no evidence to indicate that Remdesivir is beneficial in treating hospitalised coronavirus patients The second wave of the COVI